J. Lipid Res.  Neurobiology of Lipids (ISSN1683-5506)
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on November 1, 2007

Papers In Press, published online ahead of print August 24, 2007
J. Lipid Res., doi:10.1194/jlr.M700128-JLR200
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
M700128-JLR200v1
48/11/2334    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lin, C.-L.
Right arrow Articles by Lin, J.-K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, C.-L.
Right arrow Articles by Lin, J.-K.
Submitted on March 15, 2007
Revised on August 21, 2007
Accepted on August 24, 2007

Theaflavins attenuate hepatic lipid accumulation through activating AMPK in human HepG2 cells

Chih-Li Lin, Hsiu-Chen Huang, and Jen-Kun Lin

National Taiwan University Medical College, Institute of Biochemistry and Molecular Biology, Taipei 100

Corresponding Author: jklin{at}ha.mc.ntu.edu.tw

Black tea is one of the world's most popular beverages, and its health-promoting effects have been intensively investigated. The anti-obesity and hypolipidaemic effects of black tea have attracted increasing interest, but the mechanisms underlying these phenomena remain unclear. In the present study, the black tea major component theaflavins were assessed for their hepatic lipid lowering potential when administered in fatty acid overload conditions both in cell culture and an animal experimental model. In our results, we found that theaflavins significantly reduced lipid accumulation, suppressed fatty acid synthesis and stimulated fatty acid oxidation. Furthermore, theaflavins also inhibited ACC activities by stimulating AMPK through the LKB1 and ROS pathways. These observations support the idea that AMPK is a critical component of decreased hepatic lipid accumulation by theaflavin treatments. Our results show that theaflavins are bioavailable both in vitro and in vivo and may be active in the prevention of fatty liver and obesity.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.